全球阿司匹林市场 2023-2030

预计在预测期内（2023-2030年），全球阿司匹林市场将以3.6%的复合年增长率增长。有效的镇痛药，例如阿司匹林，可以帮助控制疼痛。阿司匹林具有防止血小板聚集的能力，减少血栓形成的可能性。由于其抗血小板作用，有助于降低动脉中血栓形成的风险，并防止可能导致心脏病发作或中风的阻塞。

此外，阿司匹林在降低某些癌症的风险方面发挥着重要作用，包括乳腺癌、前列腺癌、肺癌和卵巢癌。例如，根据美国国立卫生研究院 (NIH) 的报告，阿司匹林被发现可以降低患卵巢癌的风险。然而，尚不清楚遗传变量是否影响这种联繫。然而，遗传变量对此的潜在影响仍不完全清楚。了解这些影响调节剂至关重要，因为任何阿司匹林用于卵巢癌化学预防的用途都可能需要关注特定的高风险亚组。此外，抗血小板药物，包括阿司匹林和氯吡格雷，也用于治疗阿尔茨海默病。这些药物的抗血小板作用经常用于通过预防血栓形成来治疗心脏病、中风和阿尔茨海默病等疾病。例如，2023 年 1 月，FDA 快速批准了 LEQEMBITM（lecanemab-irmb）用于治疗阿尔茨海默病。阿司匹林和氯吡格雷是抗血栓药物的例子，可与 LEQEMBI 联合用于需要两种治疗的个体。

目录

第 1 章：报告摘要

• 当前行业分析及增长潜力展望
• 研究方法和工具
• 市场细分
  • 按细分
  • 按地区

第 2 章：市场概述和见解

• 报告范围
• 分析师见解和当前市场趋势
  • 主要发现
  • 建议
  • 结论

第 3 章：竞争格局

• 主要公司分析
• Bayer AG
  • 概述
  • 财务分析
  • SWOT分析
  • 最近的发展
• Cardinal Health
  • 概述
  • 财务分析
  • SWOT分析
  • 最近的发展
• LNK International, Inc.
  • 概述
  • 财务分析
  • SWOT分析
  • 最近的发展
• 关键策略分析

第 4 章：市场细分

• 按给药途径分類的全球阿司匹林市场
  • 口服
  • 直肠
  • 注射用
• 按剂型分類的全球阿司匹林市场
  • 平板电脑
  • 静脉注射
  • 胶囊
  • 糖浆
  • 其他（缓释、延迟释放、咀嚼片）
• 全球阿司匹林市场应用
  • 疼痛
  • 深层静脉栓塞
  • 发烧和炎症
  • 其他的
• 按产品类型分類的全球阿司匹林市场
  • 独自的
  • 组合产品
• 按分销渠道分類的全球阿司匹林市场
  • 医院药房
  • 零售药店
  • 网上药店

第 5 章：区域分析

• 北美
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 意大利
  • 西班牙
  • 法国
  • 欧洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 世界其他地区

第 6 章：公司简介

• Advance Pharmaceutical Inc.
• Alta laboratories Ltd.
• Endo International plc
• Globalimpoter Inc.
• Globela Pharma Pvt Ltd.
• J.M Loveridge Ltd.
• JQC (Huayin) Pharmaceutical co., Ltd.
• Nanjing Pharmatechs Co., Ltd.
• Perrigo Company plc
• Seqens
• St. Joseph Aspirin
• Thermo fisher scientific
• Trumac Healthcare
• Umang Pharmatechs co,.Ltd.
• Zhenjiang Gaopeng Pharmaceutical co,.Ltd.

Title: Global Aspirin Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Rectal, and Parenteral), by Dosage Form (Tablets, Intravenous Injections, Capsules, and Others), by Applications (Pain, Deep vein Thrombosis, Fever and Inflammation and Others), by Product Type (Alone, Combination Products), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies),Forecast Period (2023-2030).

The global aspirin market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). Effective analgesics, such as aspirin, can aid in pain management. Aspirin has the ability to prevent platelet aggregation, reducing the likelihood of blood clot formation. Due to its antiplatelet effect, helping to lower the risk of blood clot formation in the arteries and preventing blockages that can lead to heart attack or stroke.

Moreover, Aspirin plays a significant role in reducing the risk of certain cancers, including breast cancer, prostate cancer, lung cancer, and ovarian cancer. For instance, according to the National Institute of Health (NIH), aspirin has been found to lower the risk of developing ovarian cancer. however, it is unclear whether hereditary variables affect this link. Understanding impact modifiers is However, the potential impact of hereditary variables on this is still not entirely clear. Understanding these impact modifiers is crucial, as any aspirin usage for ovarian cancer chemoprevention would likely need to focus on specific higher-risk subgroups. Additionally, antiplatelet drugs, including aspirin and clopidogrel, are also used in the treatment of Alzheimer's disease. These antiplatelet effects of these drugs are frequently prescribed to treat illnesses such as heart disease, stroke, and Alzheimer's disease by preventing the formation of clots. For Instance, in January 2023, FDA granted expedited approval to LEQEMBITM (lecanemab-irmb) for the treatment of Alzheimer's disease. Aspirin and clopidogrel are examples of antithrombotic drugs that can be used in combination with LEQEMBI for individuals who require both treatments.

Segmental Outlook

The global aspirin market is segmented by route of administration, dosage form, application, product and distribution channel. Based on the route of administration the market is sub-segmented into oral, rectal, and parenteral. Based on the dosage form, the market is sub-segmented into tablets, intravenous injections, capsules, and others (syrup). Based on the application, the market is sub-segmented into pain, deep vein thrombosis, fever and inflammation and others. Based on the product type, the market is bifurcated into alone and combination. Furthermore, on the basis of the distribution channel the market is sub-segmented into hospitals pharmacies, retail pharmacies, and online pharmacies. Among the dosage forms tablets and capsules sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of market growth.

The Retail Pharmacies Sub-Segment is Anticipated to Hold a Considerable Share of the Global Aspirin Market

Among the distribution channel, the retail sub-segment is expected to hold a considerable share of the global aspirin market. Aspirin is frequently found in pharmaceuticals that can be purchased both at retail stores and online. It is primarily utilized for its analgesic, antipyretic, and anti-inflammatory effects. Its retail applications include over-the-counter (OTC) sales, self-medication, and cardiovascular health. Aspirin can be easily purchased online from the comfort of one's home, offering accessibility, convenience, and ability for large-scale purchasing. Healthcare professionals often advise aspirin use for people who are at high risk for cardiovascular events, such as heart attacks and strokes, two prevalent conditions that aspirin is regularly used to treat and prevent. As these illnesses are becoming increasingly common globally, aspirin is gaining popularity as a therapeutic and preventive tool. Therefore, the rise in the prevalence of heart disorders is a key factor in the market's expansion. For Instance, in July 2023, Techfields Pharma is currently conducting clinical research on aspirin trolamine hydrochloride, which is used in the treatment of type 2 diabetes, myocardial infarction, pulmonary embolism, and chronic heart failure. Aspirin trolamine hydrochloride can be administered both topically as a powder for a solution and transdermal as a spray. This ongoing research further contributes to the growth and development of aspirin-based treatments in the retail segment of the market.

Regional Outlook

The global aspirin market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market across the globe, owing to the high concentration of the market solution vendors including Nanjing Pharma techs Co, ltd., JQC (Huayin) Pharmaceutical Co., Ltd., Globela Pharma Pvt Ltd, Trumac Healthcare, Alta Laboratories Ltd, Zhenjiang Gaopeng Pharmaceutical CO, Ltd., and others.

North America is Expected to Grow at a Significant CAGR in the Global Aspirin Market

North America is expected to grow at a significant CAGR over the forecast period, primarily due to the high prevalence of CVDs and the increasing demand for aspirin for pain management. According to the NIH, aspirin use has been significantly associated with a decreased risk of mortality among COVID-19 individuals. Aspirin's role in primary prevention is also discussed in current recommendations. Moreover, aspirin treatment is well-acknowledged as a technique for the secondary prevention of cardiovascular events. For instance, in July 2023, Dr. Reddy's Laboratories Ltd. launched a popular statin and dual antiplatelet formulation under the trade name ROZAT GOLD. Rozat Gold is recommended for use in patients with high-risk cardiovascular conditions, such as chronic and stable coronary illnesses, by cardiologists, consulting physicians, and diabetologists. The combination of these factors is driving the growth of the aspirin market in North America, as the region focuses on managing and preventing cardiovascular diseases while recognizing the potential benefits of aspirin in various medical contexts, including its use in pain management and COVID-19 related care.

Market Players Outlook

The major companies serving the aspirin market include: Allegiant Health, Par Pharmaceutical, St. Joseph's Aspirin, Thermo Fisher Scientific Inc., Chemische Fabrik Weyl GmbH, Eli Lilly, Lohmann LTS, and Upjohn Co. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2022, Bayer AG brand Alka-Seltzer®, known for its effervescent antacids and painkillers, collaborated with the producer and musician T-Pain to introduce its newest product, NEW Alka-Seltzer hangover relief. The drug contains high-strength aspirin and caffeine, thus, advised to consumer only two drops in a glass of water for quick relief.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global aspirin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Bayer AG
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Cardinal Health
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. LNK International, Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Aspirin Market by Route of Administration
  • 4.1.1. Oral
  • 4.1.2. Rectal
  • 4.1.3. Parenteral
• 4.2. Global Aspirin Market by Dosage Form
  • 4.2.1. Tablets
  • 4.2.2. Intravenous Injections
  • 4.2.3. Capsules
  • 4.2.4. Syrups
  • 4.2.5. Others (Extended Release, Delayed Release, Chewable)
• 4.3. Global Aspirin Market by Applications
  • 4.3.1. Pain
  • 4.3.2. Deep vein Thrombosis
  • 4.3.3. Fever and Inflammation
  • 4.3.4. Others
• 4.4. Global Aspirin Market by Product Type
  • 4.4.1. Alone
  • 4.4.2. Combination Products
• 4.5. Global Aspirin Market by Distribution Channel
  • 4.5.1. Hospitals Pharmacies
  • 4.5.2. Retail Pharmacies
  • 4.5.3. Online pharmacies

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Advance Pharmaceutical Inc.
• 6.2. Alta laboratories Ltd.
• 6.3. Endo International plc
• 6.4. Globalimpoter Inc.
• 6.5. Globela Pharma Pvt Ltd.
• 6.6. J.M Loveridge Ltd.
• 6.7. JQC (Huayin) Pharmaceutical co., Ltd.
• 6.8. Nanjing Pharmatechs Co., Ltd.
• 6.9. Perrigo Company plc
• 6.10. Seqens
• 6.11. St. Joseph Aspirin
• 6.12. Thermo fisher scientific
• 6.13. Trumac Healthcare
• 6.14. Umang Pharmatechs co,.Ltd.
• 6.15. Zhenjiang Gaopeng Pharmaceutical co,.Ltd.

LIST OF TABLES

• 1. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)2022-2030 ($ MILLION)
• 2. GLOBAL ORAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 3. GLOBAL RECTAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 4. GLOBAL PARENTENAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 5. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
• 6. GLOBAL ASPIRIN IN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL ASPIRIN IN INTRAVENOUS INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL ASPIRIN IN CAPSULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL ASPIRIN IN OTHER FORMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 11. GLOBAL ASPIRIN FOR PAIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 12. GLOBAL ASPIRIN FOR DEEP VEIN THROMBOSIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 13. GLOBAL ASPIRIN FOR FEVER AND INFLAMMATION MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 14. GLOBAL ASPIRIN FOR OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 15. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 16. GLOBAL ASPIRIN IN ALONE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. GLOBAL ASPIRIN IN COMBINATION PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 18. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 19. GLOBAL ASPIRIN IN HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
• 20. GLOBAL ASPIRIN IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
• 21. GLOBAL ASPIRIN IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
• 22. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 23. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 24. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
• 25. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
• 26. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 27. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 28. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 29. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 30. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
• 31. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
• 32. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 33. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 34. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 35. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 36. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
• 37. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
• 38. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 39. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 40. ASIA- PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 41. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
• 42. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
• 43. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
• 44. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 45. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL ASPIRIN MARKET SHARE BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
• 2. GLOBAL ORAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL RECTAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL PARENTENAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022 VS 2030 (%)
• 6. GLOBAL ASPIRIN IN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL ASPIRIN IN INTRAVENOUS INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL ASPIRIN IN CAPSULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL ASPIRIN IN OTHERS FORMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022 VS 2030 (%)
• 11. GLOBAL ASPIRIN FOR PAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL ASPIRIN FOR DEEP VEIN THROMBOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 13. GLOBAL ASPIRIN FOR FEVER AND INFLAMMATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL ASPIRIN FOR OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022 VS 2030 (%)
• 16. GLOBAL ASPIRIN IN ALONE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 17. GLOBAL ASPIRIN IN COMBINATION PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 18. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• 19. GLOBAL ASPIRIN IN HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
• 20. GLOBAL ASPIRIN IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
• 21. GLOBAL ASPIRIN IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
• 22. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 23. US ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 24. CANADA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 25. UK ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 26. FRANCE ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 27. GERMANY ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 28. ITALY ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 29. SPAIN ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 30. REST OF EUROPE ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 31. INDIA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 32. CHINA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 33. JAPAN ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 34. SOUTH KOREA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 35. REST OF ASIA-PACIFIC ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
• 36. REST OF THE WORLD ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)